Search results

ANSTO recently re-started the OPAL Reactor after a six-month shutdown for essential maintenance and the installation of an upgraded facility.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

Frequently asked questions about ANSTO for the community.

The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.

It is critical across many industries to identify and locate sources of radiation accurately and quickly. By accurately imaging radiation across the full energy range, CORIS360™ improves operational decision making across many industry settings.

See details of previously published customer updates from our Health products team. 

Read about an ANSTO scientist and their work to prepare for a school project or interview.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Explore ANSTO's range of publications and reports available for the public.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Kowari, a residual stress diffractometer, can be used for ‘strain scanning’ of large engineering components as large as 1000 kilograms.

ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.

Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.